Haleon PLC
Veridion Score
Composite trend over time
Why is HLN moving today?
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for HLN.
HLN insider activity
Haleon PLC
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for HLN.
HLN contract awards, year to date.
Public federal awards linked to this ticker.
HLN lobbying filings, year to date.
Registered lobbying filings matched to Haleon PLC.